this study was conducted to assess acute oral dose-responses of four dose levels ( 2.5 , 5 , 10 , 20 mg ) of isradipine , a new calcium channel blocking agent of the 1,4-dihydropyridine group .
C0071304
isradipine
C0012315
dihydropyridine